Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00581)
| DIG Name |
Ascorbyl palmitate
|
||||
|---|---|---|---|---|---|
| Synonyms |
ASCORBYL PALMITATE; 137-66-6; L-Ascorbyl 6-palmitate; 6-O-Palmitoyl-L-ascorbic acid; L-Ascorbyl palmitate; Ascorbic palmitate; L-Ascorbic acid, 6-hexadecanoate; L-Ascorbic acid 6-palmitate; (S)-2-((R)-3,4-Dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl palmitate; UNII-QN83US2B0N; Ascorbyl monopalmitate; Ascorbyl palmitate [NF]; MFCD00005377; Ascorbic acid 6-palmitate; QN83US2B0N; Ascorboyl palmitate; Ascorbylpalmitic acid; Ascorbyl 6-palmitate; E304; Ascorbyl palmitate (NF); DSSTox_CID_21611; DSSTox_RID_79785; 6-Palmitoyl-L-ascorbic acid; DSSTox_GSID_41611; L-Ascorbyl 6-pal; Grindox 562; NSC 402451; CAS-137-66-6; 6-O-Palmitoyl ascorbate; C22H38O7; Ascorbyl palmitate (VAN); Ascorbyl 6-hexadecanoate, L-; CCRIS 3930; HSDB 418; Ascorbic acid palmitate (ester); L(+)-Ascorbyl palmitate, specified according to requirements of USP/Ph.Eur.; L-Ascorbic acid 6-hexadecanoate; [(2S)-2-[(2R)-3,4-dihydroxy-5-oxo-2H-furan-2-yl]-2-hydroxyethyl] hexadecanoate; 2-((2R)-3,4-dihydroxy-5-oxo(2-2-hydrofuryl))(2S)-2-hydroxyethyl hexadecanoate; NCGC00161605-01; EINECS 205-305-4; E 304; BRN 0096552; SCHEMBL15363; 5-18-05-00031 (Beilstein Handbook Reference); CHEMBL220190; DTXSID3041611; SCHEMBL17817668; CHEBI:140768; HY-B0987; Tox21_113637; Tox21_301926; BDBM50451094; s2532; SBB058267; AKOS015895292; ZINC100004322; ZINC100047718; CCG-207947; CS-4478; NCGC00255543-01; AS-12990; A0540; ST51016132; SW220267-1; D02412; M-6255; A807294; Q424521; 6-O-Palmitoyl-L-ascorbic acid, BioXtra, >=99.0% (RT); Ascorbic acid 6-palmitate, meets USP testing specifications; 6-O-Palmitoyl-L-ascorbic acid, analytical reference material; 6-O-Palmitoyl-L-ascorbic acid, Vetec(TM) reagent grade, 95%; Ascorbyl palmitate, European Pharmacopoeia (EP) Reference Standard; Ascorbyl palmitate, United States Pharmacopeia (USP) Reference Standard; 3,4-Dihydroxy-5beta-[(S)-2-(hexadecanoyloxy)-1-hydroxyethyl]furan-2(5H)-one; Ascorbyl Palmitate, Pharmaceutical Secondary Standard; Certified Reference Material; hexadecanoic acid [(2S)-2-[(2R)-4,5-dihydroxy-3-oxo-2-furanyl]-2-hydroxyethyl] ester; [(2S)-2-[(2R)-4,5-bis(oxidanyl)-3-oxidanylidene-furan-2-yl]-2-oxidanyl-ethyl] hexadecanoate
|
||||
| DIG Function |
Antioxidant
|
||||
| Formula |
C22H38O7
|
||||
| Canonical SMILES |
CCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O
|
||||
| InChI |
1S/C22H38O7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(24)28-16-17(23)21-19(25)20(26)22(27)29-21/h17,21,23,25-26H,2-16H2,1H3/t17-,21+/m0/s1
|
||||
| InChIKey |
QAQJMLQRFWZOBN-LAUBAEHRSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 414.5 | Topological Polar Surface Area | 113 | |
| XlogP | 6.3 | Complexity | 515 | ||
| Heavy Atom Count | 29 | Rotatable Bond Count | 18 | ||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 7 | ||
Full List of Drug(s) Co-administrated with This DIG